Cyproheptadine Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Cyproheptadine Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

CYPROHEPTADINE HYDROCHLORIDE DESCRIPTION


Cyproheptadine Hydrochloride



CLINICAL PHARMACOLOGY



PHARMACOKINETICS AND METABOLISM



INDICATIONS & USAGE










CYPROHEPTADINE HYDROCHLORIDE CONTRAINDICATIONS

Newborn or Premature Infants


Nursing Mothers


Other Conditions

DRUG INTERACTIONS.







WARNINGS

Pediatric Patients



CNS Depressants


Activities Requiring Mental Alertness

PRECAUTIONS, Geriatric Use

PRECAUTIONS

General







INFORMATION FOR PATIENTS



DRUG INTERACTIONS




CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY





PREGNANCY

Pregnancy Category B


NURSING MOTHERS

CONTRAINDICATIONS

PEDIATRIC USE

CONTRAINDICATIONS, Newborn or Premature InfantsWARNINGS, Pediatric Patients

GERIATRIC USE

WARNINGS, Activities Requiring Mental Alertness

CYPROHEPTADINE HYDROCHLORIDE ADVERSE REACTIONS



Central Nervous System


Integumentary


Special Senses


Cardiovascular


Hematologic


Digestive System


Genitourinary


Respiratory


Miscellaneous


OVERDOSAGE










DOSAGE & ADMINISTRATION




Pediatric Patients



Age 7 to 14 years


Adults


HOW SUPPLIED






STORAGE AND HANDLING





PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Cyproheptadine Hydrochloride

Cyproheptadine Hydrochloride

Cyproheptadine Hydrochloride

Cyproheptadine Hydrochloride TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-530(NDC:64980-123)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CYPROHEPTADINE HYDROCHLORIDE CYPROHEPTADINE 4 mg

Inactive Ingredients

Ingredient Name Strength
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline
STARCH, CORN

Product Characteristics

Color Size Imprint Code Shape
white 7 mm COR;150 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-530-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040537 2011-09-22


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.